Julia A Houston sold $4.3M of EFX
EVP, Strategy & Mktg Officer at EQUIFAX INC. 21,485 shares at an average of $199.50, traded Nov 15, 2023, filed Nov 17, 2023.
Score components
- +15RoleOfficer
- +25Trade size$4.3M at market
- +20Share of holdings soldSold 67% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +19.4%, 3m +26.0%, 6m +21.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-23-021106, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2023 | MOption exercise Common Stock10b5-1 | +4,326 | $121.35 | $525k | 15,060 | Nov 17, 2023 |
| Nov 15, 2023 | MOption exercise Common Stock10b5-1 | +6,238 | $127.37 | $795k | 21,298 | Nov 17, 2023 |
| Nov 15, 2023 | MOption exercise Common Stock10b5-1 | +3,378 | $134.58 | $455k | 24,676 | Nov 17, 2023 |
| Nov 15, 2023 | MOption exercise Common Stock10b5-1 | +7,543 | $138.45 | $1.0M | 32,219 | Nov 17, 2023 |
| Nov 15, 2023 | SOpen-market sale Common Stock10b5-1 | -224 | $195.02 | $44k | 31,995 | Nov 17, 2023 |
| Nov 15, 2023 | SOpen-market sale Common Stock10b5-1 | -265 | $196.77 | $52k | 31,730 | Nov 17, 2023 |
| Nov 15, 2023 | SOpen-market sale Common Stock10b5-1 | -2,902 | $198.36 | $576k | 28,828 | Nov 17, 2023 |
| Nov 15, 2023 | SOpen-market sale Common Stock10b5-1 | -10,114 | $199.02 | $2.0M | 18,714 | Nov 17, 2023 |
| Nov 15, 2023 | SOpen-market sale Common Stock10b5-1 | -2,577 | $200.13 | $516k | 16,137 | Nov 17, 2023 |
| Nov 15, 2023 | SOpen-market sale Common Stock10b5-1 | -5,403 | $201.03 | $1.1M | 10,734 | Nov 17, 2023 |
| Nov 15, 2023 | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -4,326 | $0.00 | $0 | 0 | Nov 17, 2023 |
| Nov 15, 2023 | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -6,238 | $0.00 | $0 | 0 | Nov 17, 2023 |
| Nov 15, 2023 | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -3,378 | $0.00 | $0 | 0 | Nov 17, 2023 |
| Nov 15, 2023 | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -7,543 | $0.00 | $0 | 0 | Nov 17, 2023 |
Related signals
Other insiders at EQUIFAX INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | EQUIFAX INC | John W Gamble Jr EVP, CFO & COO | $846k 4,500 shares | -6% | |
| 20Weak | EQUIFAX INC | Mark W Begor CEO | $6.5M 37,791 shares | -12% | |
| 27Weak | EQUIFAX INC | Chad M Borton EVP, Pres Workforce Solutions | $427k 2,455 shares | -8% | |
| 37Weak | EQUIFAX INC | John W Gamble Jr EVP, CFO & COO | $618k 3,500 shares | -5% | |
| 35Weak | EQUIFAX INC | Mark W Begor CEO | $6.5M 37,791 shares | -12% | |
| 40Moderate | EQUIFAX INC | John W Gamble Jr EVP, CFO & COO | $881k 4,500 shares | -7% | |
| 31Weak | EQUIFAX INC | Cecilia Mao EVP, Chief Product Officer | $465k 2,400 shares | +29% | |
| 33Weak | EQUIFAX INC | Chad M Borton EVP, Pres Workforce Solutions | $485k 2,535 shares | -13% | |
| 35Weak | EQUIFAX INC | Mark W Begor CEO | $7.6M 37,791 shares | -14% | |
| 25Weak | EQUIFAX INC | Jamil Farshchi EVP, Chief Technology Officer | $1.4M 7,380 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.